Last week, NIH’s National Institute of Allergy and Infectious Diseases (NIAID) released the exciting results of the Strategic Timing of Antiretroviral Treatment (START) study, a randomized, controlled clinical trial to more clearly define the optimal
Read More...
Read the complete post at http://blog.aids.gov/2015/06/results-from-the-start-trial-and-implications-for-the-global-treatment-of-hiv-a-conversation-with-dr-anthony-fauci.html
Posted
Jun 02 2015, 12:04 PM
by
blog.aids.gov — HIV Policy & Programs. Research. New Media.